This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rizzo, R. Articles by Robertson, M. M. Search for Related Content PubMed PubMed Citation Articles by Rizzo, R. Articles by Robertson, M. M. Social Bookmarking                         What's this?

The Successful Use of Ondansetron in a Boy With Both Leukemia and Tourette Syndrome

Section of Child Neuropsychiatry, Department of Pediatrics University of Catania, Azienda Policlinico, Catania, Italy, rerizzo{at}unict.it

Santo Marino, MD

Section of Child Onco-hematology, Department of Pediatrics University of Catania, Azienda Policlinico, Catania, Italy

Mariangela Gulisano, MD

Section of Child Neuropsychiatry, Department of Pediatrics University of Catania, Azienda Policlinico, Catania, Italy

Mary M. Robertson, MD, FRCP, FRCPCH, FRCPsych, DSc (Med)

University College, London, UK

This article reports an 8-year-old boy with both acute lymphoblastic leukemia and Gilles de la Tourette syndrome. Initially, for his leukemia, he was treated with chemotherapy, which resulted in severe nausea and vomiting for which he was given ondansetron. This not only relieved the target symptoms, but also those of his Gilles de la Tourette syndrome. Following a reduction of the ondansetron dosage, his Gilles de la Tourette syndrome symptoms reemerged.

Key Words: ondansetron • Tourette • leukemia

Journal of Child Neurology, Vol. 23, No. 1, 108-111 (2008)
DOI: 10.1177/0883073807307085


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?